ANTIHYPERGLYCEMIC EFFECTS OF VERNONIA AMYGDALINA (BITTER LEAF)
Abstract
The increasing prevalence of diabetes and the limitations of conventional treatments, there is a lack of scientifically validated and accessible alternative therapies. The potential antihyperglycemic effects of Vernonia amygdalina are not fully understood, and existing clinical studies are limited by poor design and low statistical power. This gap necessitates comprehensive research to validate the antidiabetic claims of bitter leaf and to explore its potential as a complementary or alternative treatment for diabetes.
Full-Text Access Notice
In accordance with the NERD Policy on promoting peer-reviewed publication, public access to the full text of a project, thesis or dissertation is restricted for three years, allowing the author and supervisors sufficient time to pursue peer-reviewed publication.
During this period, researchers with legitimate academic or research purposes may request authorisation directly from the author to enable NERD to release the indexed full texts of the work using the form below.